However, we found that combinations of mTORC1 and MEK1/2 inhibitors were exceptionally toxic to RAS-dependent MM cell lines in vitro and nearly eliminated tumor growth in xenograft mouse models of MM. Here, MAP2K1 is linked to Miyoshi myopathy.